Drug Profile
Flecainide
Alternative Names: Almarytm; Apocard; Aristocor; Diondel; Flecaine; Flecainide acetate; TambocorLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator 3M Pharmaceuticals
- Developer 3M Pharmaceuticals; Eisai Co Ltd
- Class Benzamides; Class Ic antiarrhythmics; Piperidines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Arrhythmias; Paroxysmal atrial fibrillation; Paroxysmal atrial flutter; Paroxysmal supraventricular tachycardia; Ventricular arrhythmias; Ventricular tachycardia
Most Recent Events
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
- 05 Aug 2016 Meda has been acquired by Mylan
- 26 Jun 2015 Launched for Paroxysmal supraventricular tachycardia, paroxysmal atrial fibrillation, ventricular tachycardia and paroxysmal atrial flutter (In children) in Japan (PO)